# Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases

> **NCT07727083** · — · RECRUITING · sponsor: **Rong Tao** · enrollment: 1500 (estimated)

## Conditions studied

- Extranodal NK/T-cell Lymphoma
- Aggressive NK-Cell Leukemia
- Systemic Chronic Active Epstein-Barr Virus Disease
- Epstein-Barr Virus-Positive Nodal T/NK-Cell Lymphoma
- Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07727083
- **Lead sponsor:** Rong Tao
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-11
- **Primary completion:** 2035-12-31
- **Final completion:** 2035-12-31
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2026-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07727083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07727083, "Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07727083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*